Update: PITNEY BOWES INC. discloses $260,000 in lobbying efforts

Recently, a lobbying disclosure revealed that PITNEY BOWES INC. spent $260,000 on lobbying in the last quarter of 2025 according to a new Lobbying Disclosure Act filing. The lobbying efforts focused on issues related to the US Postal Service, albeit without specific legislation mentioned. More detailed corporate lobbying information can be accessed on Quiver Quantitative.

Insider trading activity for $PBI showed that company insiders engaged in trading $PBI stock on the open market six times within the last six months. Of these trades, five were purchases, and one was a sale. Notable transactions include two purchases by PETER C BRIMM totaling 12,500 shares and three purchases by BRENT D ROSENTHAL totaling 5,000 shares. Additionally, LAUREN THOMAS DEFINA, the VP and Chief Accounting Officer, sold 2,000 shares. For comprehensive tracking of insider transactions, Quiver Quantitative offers an insider trading dashboard for reference.

Moreover, in terms of hedge fund activity related to PBI stock, 149 institutional investors increased their stake, while 152 decreased their positions in the most recent quarter. Some significant recent moves include VANGUARD GROUP INC removing 3,201,392 shares from their portfolio, while PRICE T ROWE ASSOCIATES INC /MD/ added 1,901,241 shares. ANCORA ADVISORS LLC removed 1,670,000 shares, CANNELL & SPEARS LLC added 1,588,579 shares, and MORGAN STANLEY removed 1,511,995 shares. DEUTSCHE BANK AG increased their holding by adding 1,490,864 shares, LSV ASSET MANAGEMENT added 1,210,500 shares to their portfolio. To monitor hedge funds’ stock portfolios, checking out Quiver Quantitative’s institutional holdings dashboard is recommended.

Various analysts have recently issued price targets for $PBI, with a median target of $11.0 based on insights from three analysts. Among these, Jasper Bibb from Truist Securities set a target price of $11.0, Aaron Kimson from Citizens proposed a target price of $13.0, and George Tong from Goldman Sachs also set a target price of $11.0. It is essential to note that the information presented in this article is not to be considered financial advice. For additional information, please refer to Quiver Quantitative’s disclaimers.